₩319000.00
₩-8000.00 (-2.45%)
End-of-day quote: 05/09/2024
KOSE:A128940

Hanmi Pharm. Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2011 2010
Rev. Revenue
₩1.49T ₩1.33T ₩1.20T ₩1.08T ₩1.11T ₩1.02T ₩916.59B ₩882.72B ₩1.32T ₩761.28B ₩730.13B ₩606.19B ₩674.76B
GM % Gross Margin %
55.62% 53.96% 52.59% 54.00% 56.79% 53.24% 56.56% 52.21% 69.74% 55.45% 56.99% 55.10% 56.79%
OM Operating Margin
15.08% 11.56% 10.42% 4.55% 9.33% 8.23% 8.96% 3.03% 16.08% 4.53% 8.48% 3.50% -1.13%
EPS Earnings Per Share
₩0.00 ₩11.52k ₩7.99k ₩5.27k ₩939.50 ₩4.17k ₩1.99k ₩4.87k ₩1.95k ₩12.07k ₩2.94k ₩4.04k ₩118.51 ₩-473.79
Div. Dividends
₩488.81 ₩490.20 ₩480.58 ₩471.16 ₩461.92 ₩452.87 ₩443.99 ₩1.74k ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩410.14
PR % Payout Ratio %
4.24% 6.13% 9.12% 50.15% 11.08% 22.72% 9.12% 89.21% 0.00% 0.00% 0.00% 0.00% -86.57%
Sha. Shares
12.69m 12.45m 12.22m 12.24m 11.77m 11.55m 11.56m 11.04m 11.59m 11.27m 10.05m 10.06m 10.07m
OCF Operating Cash Flow
₩216.54B ₩162.27B ₩201.92B ₩151.53B ₩12.45B ₩25.98B ₩-62905.20M ₩412.97B ₩101.71B ₩-32819.71M ₩85.99B ₩61.30B ₩37.89B
FCF Free Cash Flow
₩181.77B ₩131.89B ₩181.97B ₩109.72B ₩-153684.70M ₩-156285.75M ₩-309959.08M ₩212.71B ₩-19352.73M ₩-101998.70M ₩59.42B ₩41.75B ₩-497.01M
FCFS Free Cash Flow Per Share
₩13.63k ₩8.96k ₩13.72k ₩7.66k ₩-14060.18 ₩-15706.98 ₩-28900.64 ₩17.49k ₩-3024.52 ₩-9608.64 ₩4.89k ₩3.08k ₩-1223.85